317 related articles for article (PubMed ID: 16925951)
21. Multifaceted Roles of the E3 Ubiquitin Ligase RING Finger Protein 115 in Immunity and Diseases.
Wang MX; Liuyu T; Zhang ZD
Front Immunol; 2022; 13():936579. PubMed ID: 35844553
[TBL] [Abstract][Full Text] [Related]
22. E3 ubiquitin ligases as cancer targets and biomarkers.
Sun Y
Neoplasia; 2006 Aug; 8(8):645-54. PubMed ID: 16925947
[TBL] [Abstract][Full Text] [Related]
23. Role of RING-Type E3 Ubiquitin Ligases in Inflammatory Signalling and Inflammatory Bowel Disease.
Zhu L; Li Y; Zhou L; Yang G; Wang Y; Han J; Li L; Zhang S
Mediators Inflamm; 2020; 2020():5310180. PubMed ID: 32848509
[TBL] [Abstract][Full Text] [Related]
24. A central role for the ring finger protein RNF11 in ubiquitin-mediated proteolysis via interactions with E2s and E3s.
Connor MK; Seth A
Oncogene; 2004 Mar; 23(11):2089-95. PubMed ID: 15021896
[TBL] [Abstract][Full Text] [Related]
25. RING-, HECT-, and RBR-type E3 Ubiquitin Ligases: Involvement in Human Cancer.
Uchida C; Kitagawa M
Curr Cancer Drug Targets; 2016; 16(2):157-74. PubMed ID: 26560116
[TBL] [Abstract][Full Text] [Related]
26. Targeted modulation of E3 ligases using engineered ubiquitin variants.
LeBlanc N; Mallette E; Zhang W
FEBS J; 2021 Apr; 288(7):2143-2165. PubMed ID: 32867007
[TBL] [Abstract][Full Text] [Related]
27. Ring Finger Protein 11 acts on ligand-activated EGFR via the direct interaction with the UIM region of ANKRD13 protein family.
Mattioni A; Boldt K; Auciello G; Komada M; Rappoport JZ; Ueffing M; Castagnoli L; Cesareni G; Santonico E
FEBS J; 2020 Aug; 287(16):3526-3550. PubMed ID: 31985874
[TBL] [Abstract][Full Text] [Related]
28. Arkadia--beyond the TGF-β pathway.
Miyazono K; Koinuma D
J Biochem; 2011 Jan; 149(1):1-3. PubMed ID: 21109559
[TBL] [Abstract][Full Text] [Related]
29. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
30. Cell regulation by phosphotyrosine-targeted ubiquitin ligases.
Cooper JA; Kaneko T; Li SS
Mol Cell Biol; 2015 Jun; 35(11):1886-97. PubMed ID: 25776560
[TBL] [Abstract][Full Text] [Related]
31. Overview of the membrane-associated RING-CH (MARCH) E3 ligase family.
Bauer J; Bakke O; Morth JP
N Biotechnol; 2017 Sep; 38(Pt A):7-15. PubMed ID: 27988304
[TBL] [Abstract][Full Text] [Related]
32. RBR E3 ubiquitin ligases in tumorigenesis.
Wang P; Dai X; Jiang W; Li Y; Wei W
Semin Cancer Biol; 2020 Dec; 67(Pt 2):131-144. PubMed ID: 32442483
[TBL] [Abstract][Full Text] [Related]
33. E3 ligase activity and suppression of breast cancer.
Eggleston AK
Nat Struct Mol Biol; 2004 Jan; 11(1):8. PubMed ID: 14718914
[No Abstract] [Full Text] [Related]
34. E3 ubiquitin ligase SIAH1 mediates ubiquitination and degradation of TRB3.
Zhou Y; Li L; Liu Q; Xing G; Kuai X; Sun J; Yin X; Wang J; Zhang L; He F
Cell Signal; 2008 May; 20(5):942-8. PubMed ID: 18276110
[TBL] [Abstract][Full Text] [Related]
35. How ubiquitination regulates the TGF-β signalling pathway: new insights and new players: new isoforms of ubiquitin-activating enzymes in the E1-E3 families join the game.
Soond SM; Chantry A
Bioessays; 2011 Oct; 33(10):749-58. PubMed ID: 21932223
[TBL] [Abstract][Full Text] [Related]
36. E3 ubiquitin ligases in cancer and implications for therapies.
Wang D; Ma L; Wang B; Liu J; Wei W
Cancer Metastasis Rev; 2017 Dec; 36(4):683-702. PubMed ID: 29043469
[TBL] [Abstract][Full Text] [Related]
37. Pellino proteins are more than scaffold proteins in TLR/IL-1R signalling: a role as novel RING E3-ubiquitin-ligases.
Schauvliege R; Janssens S; Beyaert R
FEBS Lett; 2006 Aug; 580(19):4697-702. PubMed ID: 16884718
[TBL] [Abstract][Full Text] [Related]
38. Ubiquitination system and autoimmunity: the bridge towards the modulation of the immune response.
Gómez-Martín D; Díaz-Zamudio M; Alcocer-Varela J
Autoimmun Rev; 2008 Feb; 7(4):284-90. PubMed ID: 18295731
[TBL] [Abstract][Full Text] [Related]
39. Genetic and expression aberrations of E3 ubiquitin ligases in human breast cancer.
Chen C; Seth AK; Aplin AE
Mol Cancer Res; 2006 Oct; 4(10):695-707. PubMed ID: 17050664
[TBL] [Abstract][Full Text] [Related]
40. Novel Insights Into E3 Ubiquitin Ligase in Cancer Chemoresistance.
Yang L; Chen J; Huang X; Zhang E; He J; Cai Z
Am J Med Sci; 2018 Apr; 355(4):368-376. PubMed ID: 29661351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
